Tampere, Finland — 24th November 2025 Neuro Event Labs Oy (NEL), a global healthcare diagnostics…
Continue Reading-
Step Pharma announces completion of €38 million Series C financing
Step Pharma announces completion of €38 million Series C financing • Financing will support the…
Continue Reading -
Complement Therapeutics Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy secondary to AMD
Complement Therapeutics Receives FDA IND Clearance...
Continue Reading -
Ribbon Bio and Scala Biodesign into Powerful Partnership Focused on Customers
In Powerful Partnership Focused on Customers, Ribbon Bio and Scala Biodesign Advance Enzyme Innovation with…
Continue Reading -
ARTHEx Biotech Upsizes Series B Financing Round to $87M to Advance Lead Program ATX-01 in Myotonic Dystrophy Type 1 and Expand Pipeline of Targeted RNA Medicines
ARTHEx Biotech Upsizes Series B Financing Round to $87M...
Continue Reading -
Gesynta Pharma Announces Second Closing of Series B Now Totaling SEK 347m – HealthCap and Hadean Growth Fund Join Strong Investor Syndicate
STOCKHOLM, SWEDEN – July 22, 2025. Gesynta Pharma AB today announced it has raised an…
Continue Reading -
SAGA Diagnostics® Announces Medicare Coverage for Pathlight™ MRD Test in Breast Cancer Across All Subtypes
Coverage marks a pivotal step in expanding access to ultra-sensitive MRD detection for breast cancer…
Continue Reading -
Ribbon Bio and Syngoi Technologies Commence Strategic Collaboration to Advance Gene Therapies with Synthetic DNA
Collaboration builds upon Syngoi’s synthetic DNA manufacturing capabilities and Ribbon’s algorithm-driven technology to produce pristine…
Continue Reading -
Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period
Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of…
Continue Reading
